Wolverine Asset Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,600
Closed -$37K 1665
2020
Q3
$37K Sell
14,600
-273,500
-95% -$703K ﹤0.01% 1317
2020
Q2
$656K Sell
288,100
-70,800
-20% -$151K 0.01% 656
2020
Q1
$376K Sell
358,900
-407,800
-53% -$1.38M 0.01% 749
2019
Q4
$2.8M Buy
766,700
+99,700
+15% +$344K 0.03% 367
2019
Q3
$2.43M Buy
667,000
+130,900
+24% +$560K 0.03% 371
2019
Q2
$2.25M Buy
536,100
+230,100
+75% +$920K 0.03% 405
2019
Q1
$1.09M Buy
306,000
+169,600
+124% +$564K 0.01% 624
2018
Q4
$301K Buy
136,400
+40,900
+43% +$169K ﹤0.01% 1161
2018
Q3
$611K Buy
95,500
+72,000
+306% +$511K 0.01% 964
2018
Q2
$175K Buy
+23,500
New +$177K ﹤0.01% 1118
2017
Q4
Sell
-115,600
Closed -$965K 1457
2017
Q3
$965K Hold
115,600
0.01% 673
2017
Q2
$491K Buy
+115,600
New +$464K 0.01% 795
2014
Q2
Sell
-12
Closed -$1K 2348
2014
Q1
$1K Buy
+12
New +$327 ﹤0.01% 2213

Other funds holding CLMT

Wolverine Asset Management's CLMT Position: Q2 2014 in Review

Wolverine Asset Management sold out of Calumet Specialty Products (CLMT) in Q2 2014, closing a stake of 5,100 shares — an estimated $131K sold.

Wolverine Asset Management first reported a position in CLMT in Q2 2013 and held it in 4 quarters. The position peaked at $257K in Q4 2013. 124 funds tracked by Wall St. Rank hold CLMT as of Q2 2014.

  • Wolverine Asset Management reported no remaining Calumet Specialty Products position as of Q2 2014 after selling out during the quarter.
  • Wolverine Asset Management sold 5,100 Calumet Specialty Products shares in Q2 2014, an estimated $131K.
  • Wolverine Asset Management first reported a position in Calumet Specialty Products in Q2 2013 and held it in 4 quarters.
  • Wolverine Asset Management's Calumet Specialty Products position peaked at $257K in Q4 2013.
  • 124 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2014.

Based on Wolverine Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.